P

Inventor

GROMPE MARKUS

US12 patents
⚠️ This page may combine multiple inventors who share the name “GROMPE MARKUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GROMPE MARKUS

5 patents
US9000257B2Apr 7, 2015

Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof

GROMPE MARKUS10 citations77
US8569573B2Oct 29, 2013

Method of expanding human hepatocytes in vivo

GROMPE MARKUS7 citations75
US8247186B2Aug 21, 2012

Monoclonal antibodies and their use

GROMPE MARKUS3 citations55
US8097428B2Jan 17, 2012

Monoclonal antibodies and their use

GROMPE MARKUS0 citations44
US9566315B2Feb 14, 2017

Normalization of the enterohepatic circulation in animals with a chimeric humanized liver

GROMPE MARKUS0 citations40

DANA FARBER CANCER INST INC

2 patents
US11421218B2Aug 23, 2022

Methods for enhancing the efficiency of gene editing

DANA FARBER CANCER INST INC0 citations61
US9354224B2May 31, 2016

Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof

DANA FARBER CANCER INST INC0 citations45

UNIV OREGON HEALTH & SCIENCE

2 patents
US7981628B2Jul 19, 2011

Monoclonal antibodies and their use

UNIV OREGON HEALTH & SCIENCE0 citations44
US12584131B2Mar 24, 2026

Methods of gene therapy

UNIV OREGON HEALTH & SCIENCE0 citations41

UNIV OREGON HEALTH SCIENCES

1 patent
US6132708AOct 17, 2000

Liver regeneration using pancreas cells

UNIV OREGON HEALTH SCIENCES11 citations71

MAY FOUND FOR MEDICAL EDUCATION AND RES

1 patent
US9485971B2Nov 8, 2016

Fumarylacetoacetate hydrolase (Fah)-deficient pigs and uses thereof

MAY FOUND FOR MEDICAL EDUCATION AND RES3 citations61

DANA-FARBER CANCER INSTITUTE INC

1 patent
US10738310B2Aug 11, 2020

Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor

DANA-FARBER CANCER INSTITUTE INC0 citations49